Review



capsaicin cap  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress capsaicin cap
    Capsaicin Cap, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 56 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/capsaicin cap/product/MedChemExpress
    Average 94 stars, based on 56 article reviews
    capsaicin cap - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    96
    ATCC mouse myccap cells
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Mouse Myccap Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse myccap cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    mouse myccap cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress capsaicin cap
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Capsaicin Cap, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/capsaicin cap/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    capsaicin cap - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Gerstel GmbH screw cap
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Screw Cap, supplied by Gerstel GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/screw cap/product/Gerstel GmbH
    Average 90 stars, based on 1 article reviews
    screw cap - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    brain products gmbh eeg cap
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Eeg Cap, supplied by brain products gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eeg cap/product/brain products gmbh
    Average 90 stars, based on 1 article reviews
    eeg cap - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Capricor Inc cap-1002a
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Cap 1002a, supplied by Capricor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cap-1002a/product/Capricor Inc
    Average 90 stars, based on 1 article reviews
    cap-1002a - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Capricor Inc cap-1002b
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Cap 1002b, supplied by Capricor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cap-1002b/product/Capricor Inc
    Average 90 stars, based on 1 article reviews
    cap-1002b - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Croda International Plc biotin pe
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Biotin Pe, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin pe/product/Croda International Plc
    Average 95 stars, based on 1 article reviews
    biotin pe - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    96
    ATCC mouse myccap pca cell lines
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Mouse Myccap Pca Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse myccap pca cell lines/product/ATCC
    Average 96 stars, based on 1 article reviews
    mouse myccap pca cell lines - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    95
    Thermo Fisher well cap mats
    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a <t>),</t> <t>A549</t> ( b ), or <t>MycCaP</t> ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.
    Well Cap Mats, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/well cap mats/product/Thermo Fisher
    Average 95 stars, based on 1 article reviews
    well cap mats - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a ), A549 ( b ), or MycCaP ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.

    Journal: Nature Communications

    Article Title: Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS

    doi: 10.1038/s41467-026-68913-3

    Figure Lengend Snippet: Differential cell toxicity following treatment with HYDRAC or P-sHR. Representative dose-response plots of PC3 ( a ), A549 ( b ), or MycCaP ( c ) cells following 72 h treatment with viability normalized to vehicle-treated control from n = 3 technical replicates. d Summary IC 50 values in PC3 and A549 cells following treatment with indicated polymers averaged from n = 3 independent biological experiments with > 2 different batch formulations. e Annexin V/PI staining of PC3 cells treated for 24 h with HYDRAC analyzed by flow cytometry and split into late (Annexin V-FITC + /PI + ) and early (Annexin V-FITC + /PI + ) stage apoptosis. The DMSO group was incubated with 10% DMSO as a positive control. n = 3 independent samples per group. Experiment repeated with similar results. f Representative dose-response curves of PC3 cells treated for 72 h with HYDRACs consisting of different targeting ligand to degron ratios with viability normalized to vehicle-treated controls. g PC3 (solid) or PC12 (dashed) cells were treated with HYDRAC for 72 h and cell viability was normalized to vehicle treatment. IC 50 values listed. h A549 cells were incubated with a single treatment of 10 or 20 μM of the indicated polymer formulations at day 0, and cell counts were normalized to the initial seeding amount monitored over 2 weeks. Data depict mean ± s.d. P -values determined by one-way ANOVA in d, e . One representative dose-response or proliferation curve from n = 3 independent experiments is shown in ( f), ( g ), and ( h ). * P < 0.05, ** P < 0.01, ns: not significant.

    Article Snippet: PC-3, PC-12, A549, 293T, and HCT116 cells were obtained from ATCC; Mouse MycCaP cells were the kind gift of Charles Sawyers (Memorial Sloan-Kettering Cancer Centre); HCT116 KEAP1 KO cells were obtained from Abcam (ab286484); 293 T VHL KO cells were obtained from Creative Biogene (CSC-RT2714).

    Techniques: Control, Staining, Flow Cytometry, Incubation, Positive Control, Polymer